GO:0097011 cellular response to granulocyte macrophage colony-stimulating factor stimulus: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0097011 describes any process by which a cell changes its state or activity in response to granulocyte macrophage colony-stimulating factor (GM-CSF).
• GM-CSF is a hematologic growth factor that acts on myeloid progenitors, neutrophils, monocytes, macrophages, and dendritic cells [1, 2].
• The cellular response to GM-CSF includes changes in movement, secretion, enzyme production, and gene expression.
• GM-CSF signaling is stimulus-dependent and is required for inflammation in some contexts but not others.
• Dysregulated GM-CSF responses are linked to juvenile chronic myeloid leukemia and inflammatory disease [7, 3].
• Experimental models for GO:0097011 include knockout, point-mutation, knock-in, and overexpression cell systems, plus CRISPR library screening.
Description
GO:0097011, cellular response to granulocyte macrophage colony-stimulating factor stimulus, is a biological process term in the Gene Ontology that captures how a cell reacts to GM-CSF. GM-CSF is a hematologic growth factor that regulates the production, differentiation, and function of granulocytes and macrophages. The term covers changes in cell movement, secretion, enzyme production, gene expression, and other activities triggered by GM-CSF. Researchers study this process to understand myeloid cell biology, inflammation, and leukemia [2, 3, 7]. Because GM-CSF acts on multiple target cell types, the cellular response is context-dependent and can differ between neutrophils, monocytes, dendritic cells, and progenitor cells [2, 6, 8].
cellular response to granulocyte macrophage colony-stimulating factor stimulus At A Glance
| GO ID | GO:0097011 |
|---|---|
| GO term | cellular response to granulocyte macrophage colony-stimulating factor stimulus |
| Ontology | biological_process |
| Synonym | cellular response to GM-CSF stimulus |
| Major function | Mediates cellular changes in movement, secretion, enzyme production, and gene expression in response to GM-CSF |
| Stimulus | Granulocyte macrophage colony-stimulating factor (GM-CSF) |
| Target cells | Myeloid progenitors, neutrophils, monocytes, macrophages, dendritic cells [2, 6, 8] |
| Disease relevance | Juvenile chronic myeloid leukemia, inflammation [7, 3] |
| Research methods | Knockout, point mutation, knock-in, overexpression, CRISPR library screening |
What Is GO:0097011?
In simple terms, GO:0097011 means any change in a cell's state or behavior caused by GM-CSF. The official definition states: any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a granulocyte macrophage colony-stimulating factor stimulus. The synonym is cellular response to GM-CSF stimulus. This is a biological process term, meaning it describes a series of molecular events rather than a single molecular function or cellular component.
Why Is cellular response to granulocyte macrophage colony-stimulating factor stimulus Important in Cell Biology?
The cellular response to GM-CSF is important because GM-CSF is a central regulator of myeloid cell biology and inflammation [1, 3]. It controls the survival, proliferation, differentiation, and activation of granulocytes and macrophages, which are essential for host defense and tissue homeostasis [1, 2]. Dysregulated GM-CSF responses contribute to hematologic malignancies such as juvenile chronic myeloid leukemia and to chronic inflammatory conditions [7, 3]. Understanding GO:0097011 helps researchers identify therapeutic targets and design experiments that modulate myeloid cell function.
• GM-CSF is a hematologic growth factor that regulates granulocyte and macrophage production.
• The cellular response to GM-CSF includes changes in cell movement, secretion, enzyme production, and gene expression.
• GM-CSF acts on multiple target cells, including neutrophils, monocytes, and dendritic cells [2, 6, 8].
• Stimulus-dependent GM-CSF is required for inflammation in some models.
• Juvenile chronic myeloid leukemia progenitors show selective hypersensitivity to GM-CSF.
• GM-CSF can induce functionally competent dendritic cells in the brain.
• GM-CSF is produced by non-hematopoietic cells such as tracheal epithelial cells.
• The response to GM-CSF involves biochemical changes in neutrophils.
• GM-CSF and interleukin-3 share target cells and kinetics of response in vivo [2, 4].
• Studying GO:0097011 supports drug discovery for inflammatory and myeloid diseases [3, 7].
What Happens During cellular response to granulocyte macrophage colony-stimulating factor stimulus?
GM-CSF binding and receptor activation
In simple terms: GM-CSF docks onto its receptor on the cell surface, switching the cell on.
The cellular response to GM-CSF begins when GM-CSF binds to its receptor on the surface of target cells. This binding activates intracellular signaling cascades that change the cell's state or activity. GM-CSF acts on myeloid progenitors, neutrophils, monocytes, macrophages, and dendritic cells [2, 6, 8].
Changes in gene expression and enzyme production
In simple terms: The cell starts making different proteins and enzymes.
A key outcome of the cellular response to GM-CSF is a change in gene expression and enzyme production. GM-CSF stimulation alters the transcriptional program of target cells, leading to new protein synthesis and altered enzyme activities. These changes support differentiation, survival, and functional activation of myeloid cells [1, 2].
Secretion and movement
In simple terms: The cell releases factors and moves in response to GM-CSF.
The cellular response to GM-CSF includes changes in secretion and cell movement. GM-CSF-stimulated cells can release cytokines and other mediators, and they can migrate to sites of inflammation [1, 3]. These activities are part of the functional response that links GM-CSF to inflammation.
Kinetics of response in vivo
In simple terms: The response happens over time and can be measured in living animals.
The kinetics of the cellular response to GM-CSF have been studied in vivo, showing that target cells respond with specific timing [2, 4]. GM-CSF and interleukin-3 share target cells and kinetics of response in vivo [2, 4]. This temporal dimension is important for understanding how GM-CSF drives myeloid cell expansion and activation.
Stimulus-dependent requirement in inflammation
In simple terms: GM-CSF is needed for some inflammatory responses but not all.
The requirement for GM-CSF in inflammation is stimulus-dependent. In some experimental models, GM-CSF is essential for the cellular response that drives inflammation, while in others it is not. This context dependence highlights the importance of studying GO:0097011 under defined conditions.
Key Genes Involved in GO:0097011 cellular response to granulocyte macrophage colony-stimulating factor stimulus
The following genes and proteins are central to the cellular response to GM-CSF, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CSF2 | Encodes GM-CSF, the ligand that initiates the response | Target for knockout and overexpression studies |
| CSF2RA | Alpha subunit of the GM-CSF receptor | Knockout and point-mutation models |
| CSF2RB | Beta subunit of the GM-CSF receptor | Knock-in and tagged knock-in studies |
| JAK2 | Tyrosine kinase activated downstream of GM-CSF receptor | Point-mutation and knockout models |
| STAT5A | Transcription factor mediating GM-CSF-induced gene expression | Knockout and overexpression studies |
| STAT5B | Transcription factor mediating GM-CSF-induced gene expression | Knockout and overexpression studies |
| SPI1 | Myeloid transcription factor involved in GM-CSF responses | Knockout and point-mutation models |
| CEBPA | Transcription factor regulating myeloid differentiation | Knockout and overexpression studies |
| IL3 | Cytokine sharing target cells and kinetics with GM-CSF [2, 4] | Comparative knockout studies |
| IL3RA | Alpha subunit of the IL-3 receptor | Knockout and point-mutation models |
| ITGAM | Integrin involved in neutrophil and monocyte function | Knockout and tagged knock-in studies |
| FCGR3B | Receptor involved in neutrophil activation | Knockout and overexpression models |
| CD83 | Dendritic cell maturation marker induced by GM-CSF | Knock-in reporter studies |
| ITGAX | Integrin expressed on dendritic cells and macrophages | Knockout and overexpression studies |
| CCL2 | Chemokine involved in inflammatory cell recruitment | Knockout and point-mutation models |
| TNF | Cytokine produced in inflammatory responses | Knockout and overexpression studies |
| IL6 | Cytokine produced in inflammatory responses | Knockout and overexpression studies |
How Is cellular response to granulocyte macrophage colony-stimulating factor stimulus Regulated?
The cellular response to GM-CSF is regulated at multiple levels. Receptor activation triggers intracellular signaling that can be modulated by feedback mechanisms. The requirement for GM-CSF in inflammation is stimulus-dependent, meaning that the strength and context of the stimulus influence the response. GM-CSF and interleukin-3 share target cells and kinetics of response in vivo, suggesting overlapping regulatory networks [2, 4]. In juvenile chronic myeloid leukemia, progenitors show selective hypersensitivity to GM-CSF, indicating dysregulated regulation of this response.
cellular response to granulocyte macrophage colony-stimulating factor stimulus and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CSF2 | Inflammation and myeloid cell activation | Knockout and overexpression cell models |
| CSF2RA | Juvenile chronic myeloid leukemia hypersensitivity | Point-mutation and knockout models |
| CSF2RB | GM-CSF receptor signaling in leukemia | Knock-in and tagged knock-in models |
| JAK2 | Myeloid malignancy and inflammation | Point-mutation and knockout models |
| STAT5A | Leukemia and inflammatory responses | Knockout and overexpression models |
Juvenile chronic myeloid leukemia
Juvenile chronic myeloid leukemia hematopoietic progenitors show selective hypersensitivity to GM-CSF. This hypersensitivity suggests that the cellular response to GM-CSF is abnormally amplified in this disease, contributing to abnormal myeloid proliferation. Studying GO:0097011 in this context can reveal targets for therapeutic intervention.
Inflammation
GM-CSF is required for inflammation in a stimulus-dependent manner. The cellular response to GM-CSF drives the recruitment and activation of inflammatory cells, and blocking this response can reduce inflammation in some models. This makes GO:0097011 relevant to chronic inflammatory diseases.
Neuroinflammation and dendritic cell function
Intracerebral GM-CSF induces functionally competent dendritic cells in the mouse brain. This indicates that the cellular response to GM-CSF can occur in the central nervous system and may contribute to neuroinflammatory processes. Understanding this response could inform therapies for brain inflammation.
From cellular response to granulocyte macrophage colony-stimulating factor stimulus-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CSF2 abolish the cellular response to GM-CSF? | CSF2 knockout cell line |
| Does a specific point mutation in CSF2RA alter GM-CSF signaling? | CSF2RA point-mutation knock-in |
| Can a tagged GM-CSF receptor be used to track localization? | Tagged knock-in of CSF2RB |
| Does overexpression of STAT5A enhance GM-CSF-induced gene expression? | STAT5A overexpression cell line |
| Which genes are required for GM-CSF-induced inflammation? | CRISPR library screening in myeloid cells |
| Does GM-CSF induce dendritic cell maturation in the brain? | Intracerebral GM-CSF administration in mice |
How to Study the cellular response to granulocyte macrophage colony-stimulating factor stimulus Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Changes in gene expression | Identifying GM-CSF-induced transcriptional programs |
| Proteomics | Changes in protein abundance | Detecting enzyme production changes |
| Enzyme assays | Enzyme activity | Measuring biochemical effects of GM-CSF |
| Flow cytometry | Cell surface markers and activation | Assessing dendritic cell maturation |
| Imaging | Cell movement and localization | Tracking migration in response to GM-CSF |
| CRISPR library screening | Gene essentiality for the response | Identifying novel regulators |
| Bioinformatics | Pathway and network analysis | Interpreting screening and omics data |
Transcriptomics and RNA-seq
RNA sequencing can measure changes in gene expression that occur during the cellular response to GM-CSF. By comparing GM-CSF-stimulated and unstimulated cells, researchers can identify genes whose expression is altered. This approach is useful for defining the transcriptional program downstream of GM-CSF.
Proteomics and enzyme assays
Proteomic methods and enzyme assays can detect changes in protein production and enzyme activity during the cellular response to GM-CSF [1, 6]. These methods help quantify the biochemical effects of GM-CSF on target cells such as neutrophils.
Flow cytometry and imaging
Flow cytometry and imaging can assess changes in cell surface markers, movement, and secretion in response to GM-CSF. These methods are particularly useful for studying dendritic cell maturation and migration.
CRISPR screening and bioinformatics
CRISPR library screening combined with bioinformatics can identify genes that are required for the cellular response to GM-CSF. This unbiased approach can reveal novel regulators of the response and prioritize therapeutic targets.
How CRISPR Can Be Used to Study GO:0097011 cellular response to granulocyte macrophage colony-stimulating factor stimulus
Knockout
CRISPR knockout can be used to delete genes such as CSF2, CSF2RA, or CSF2RB to test whether they are required for the cellular response to GM-CSF. Knockout cell models provide a clean background to study loss-of-function effects.
Point Mutation
CRISPR point mutation can introduce specific amino acid changes in genes like JAK2 or STAT5A to dissect signaling domains required for the GM-CSF response. These models help distinguish between different signaling branches.
Knock-in
CRISPR knock-in can add tags or reporters to genes such as CSF2RB or CD83 to track receptor localization or dendritic cell maturation in response to GM-CSF. Tagged knock-in models enable live-cell imaging and biochemical purification.
Overexpression
CRISPR overexpression can drive high-level expression of genes like STAT5A or CSF2 to test whether increased dosage enhances or dysregulates the cellular response to GM-CSF. Overexpression models are useful for studying gain-of-function phenotypes.
How EDITGENE Supports cellular response to granulocyte macrophage colony-stimulating factor stimulus Research
Researchers studying cellular response to granulocyte macrophage colony-stimulating factor stimulus-related genes often need to determine whether a candidate gene is causally involved in the response or is merely correlated with it. EDITGENE provides CRISPR-based cell model services that enable precise genetic perturbations to answer these questions.
Contact EDITGENE today to design your custom CRISPR model for cellular response to granulocyte macrophage colony-stimulating factor stimulus research.
Frequently Asked Questions About cellular response to granulocyte macrophage colony-stimulating factor stimulus
What is GO:0097011?
GO:0097011 is the Gene Ontology term for cellular response to granulocyte macrophage colony-stimulating factor stimulus, describing any change in a cell's state or activity caused by GM-CSF.
What is the definition of cellular response to granulocyte macrophage colony-stimulating factor stimulus?
It is any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a GM-CSF stimulus.
What genes are involved in the cellular response to GM-CSF?
Genes include CSF2, CSF2RA, CSF2RB, JAK2, STAT5A, STAT5B, SPI1, and CEBPA, among others.
What diseases are linked to GM-CSF responses?
Juvenile chronic myeloid leukemia and inflammatory diseases are linked to dysregulated GM-CSF responses [7, 3].
How is the cellular response to GM-CSF studied?
It is studied using RNA-seq, proteomics, flow cytometry, imaging, and CRISPR screening [1, 6, 8].
What cell types respond to GM-CSF?
Myeloid progenitors, neutrophils, monocytes, macrophages, and dendritic cells respond to GM-CSF [2, 6, 8].
Is GM-CSF required for inflammation?
The requirement for GM-CSF in inflammation is stimulus-dependent.
Can GM-CSF act in the brain?
Yes, intracerebral GM-CSF induces functionally competent dendritic cells in the mouse brain.
What is the synonym for GO:0097011?
The synonym is cellular response to GM-CSF stimulus.
How can CRISPR help study GO:0097011?
CRISPR knockout, point mutation, knock-in, and overexpression models can test the role of specific genes in the GM-CSF response.
Conclusion
GO:0097011, cellular response to granulocyte macrophage colony-stimulating factor stimulus, is a key biological process that governs how myeloid cells respond to GM-CSF. It encompasses changes in gene expression, secretion, movement, and enzyme production, and it is relevant to inflammation and leukemia [1, 3, 7]. Researchers can use CRISPR-based models and omics methods to dissect the genes and pathways involved [1, 8].
References
- 1. Unknown. 2012. Hematologic Growth Factors.. PMID: 31644052
- 2. Aglietta M et al.. 1993. Granulocyte-macrophage colony stimulating factor and interleukin 3: target cells and kinetics of response in vivo.. Stem Cells 11 Suppl 2:83-7 PMID: 8401260
- 3. Cook AD et al.. 2004. Stimulus-dependent requirement for granulocyte-macrophage colony-stimulating factor in inflammation.. J Immunol 173(7):4643-51 PMID: 15383599
- 4. Aglietta M et al.. 1993. Interleukin-3 in vivo: kinetic of response of target cells.. Blood 82(7):2054-61 PMID: 8400256
- 5. Churchill L et al.. 1992. Production of granulocyte-macrophage colony-stimulating factor by cultured human tracheal epithelial cells.. Immunology 75(1):189-95 PMID: 1537596
- 6. Sullivan R. 1992. Biochemical effects of human granulocyte-macrophage colony-stimulating factor (GM-CSF) on the human neutrophil.. Immunol Ser 57:485-98 PMID: 1387006
- 7. Emanuel PD et al.. 1991. Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors.. Blood 77(5):925-9 PMID: 1704804
- 8. Mausberg AK et al.. 2009. Intracerebral granulocyte-macrophage colony-stimulating factor induces functionally competent dendritic cells in the mouse brain.. Glia 57(12):1341-50 PMID: 19229994
